Merck and Co Inc (MRK) Actualités

Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK

Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action...

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc.(MRK) Shareholders

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc.(MRK...

Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRK

Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for...

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRK

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit...

Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class Action - Contact The Gross Law...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Acceptance based on results from the KEYNOTE-689 trial: the first Phase 3 trial to demonstrate significant improvement in event-free survival in...

Merck to Participate in the TD Cowen 45th Annual Health Care Conference

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Caroline Litchfield, executive vice president and...

The Gross Law Firm Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRK

The Gross Law Firm Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline...

Form 4 - Statement of changes in beneficial ownership of securities

Merck & Co., Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights - MRK

Merck & Co., Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 14, 2025 to...

Form 144 - Report of proposed sale of securities

WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications

WELIREG is the first and only oral hypoxia-inducible factor-2 alpha inhibitor approved in the European Union Merck (NYSE: MRK), known as MSD...

Form 13F-HR - Quarterly report filed by institutional managers, Holdings

Form 144 - Report of proposed sale of securities